Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D T Manallack

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Experimental Brain Research|January 1, 1991
Evidence for heterogenous glycine domains but conserved multiple states of the excitatory amino acid recognition site of the NMDA receptor: regional binding studies with [3H]glycine and [3H]L-glutamateR D O'Shea, D T Manallack, E L Conway, et al.
Toxicology|December 4, 1992
Multivariate quantitative structure-toxicity relationships in a series of dopamine mimeticsJ E Ridings, D T Manallack, M R Saunders, et al.
Arzneimittel-Forschung|October 1, 1993
Analysis of the biological and molecular properties of phencyclidine-like compounds by chemometricsD T Manallack, J W Davies, P M Beart, et al.
Scientific Reports|October 31, 2019
IRAK3 modulates downstream innate immune signalling through its guanylate cyclase activityL A Freihat, J I Wheeler, A Wong, et al.
Current Medicinal Chemistry|July 1, 2010
Synthesis and preliminary screening of novel tryptamines as 5-HT4 receptor ligandsA Hanna-Elias, D T Manallack, I Berque-Bestel, et al.
Bioorganic & Medicinal Chemistry|January 30, 1999
The design, synthesis, and evaluation of novel conformationally rigid analogues of sialyl Lewis(x)P V Murphy, R E Hubbard, D T Manallack, et al.
Current Medicinal Chemistry|September 23, 2010
Use of Kv1.3 blockers for inflammatory skin conditionsW Nguyen, B L Howard, D S Neale, et al.
Protein and Peptide Letters|July 16, 2009
The use of tripeptides for lead discovery of 5-HT4 receptor ligandsA Hanna-Elias, P E Thompson, D T Manallack, et al.
British Journal of Pharmacology|November 1, 1988
A comparison between the in vivo and in vitro activity of five potent and competitive NMDA antagonistsD Lodge, S N Davies, M G Jones, et al.
Bioorganic & Medicinal Chemistry Letters|May 30, 2001
Arylsulphonyl hydroxamic acids: potent and selective matrix metalloproteinase inhibitorsA D Baxter, R Bhogal, J Bird, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Experimental Brain Research|January 1, 1991
Evidence for heterogenous glycine domains but conserved multiple states of the excitatory amino acid recognition site of the NMDA receptor: regional binding studies with [3H]glycine and [3H]L-glutamateR D O'Shea, D T Manallack, E L Conway, et al.
Toxicology|December 4, 1992
Multivariate quantitative structure-toxicity relationships in a series of dopamine mimeticsJ E Ridings, D T Manallack, M R Saunders, et al.
Arzneimittel-Forschung|October 1, 1993
Analysis of the biological and molecular properties of phencyclidine-like compounds by chemometricsD T Manallack, J W Davies, P M Beart, et al.
Scientific Reports|October 31, 2019
IRAK3 modulates downstream innate immune signalling through its guanylate cyclase activityL A Freihat, J I Wheeler, A Wong, et al.
Current Medicinal Chemistry|July 1, 2010
Synthesis and preliminary screening of novel tryptamines as 5-HT4 receptor ligandsA Hanna-Elias, D T Manallack, I Berque-Bestel, et al.
Bioorganic & Medicinal Chemistry|January 30, 1999
The design, synthesis, and evaluation of novel conformationally rigid analogues of sialyl Lewis(x)P V Murphy, R E Hubbard, D T Manallack, et al.
Current Medicinal Chemistry|September 23, 2010
Use of Kv1.3 blockers for inflammatory skin conditionsW Nguyen, B L Howard, D S Neale, et al.
Protein and Peptide Letters|July 16, 2009
The use of tripeptides for lead discovery of 5-HT4 receptor ligandsA Hanna-Elias, P E Thompson, D T Manallack, et al.
British Journal of Pharmacology|November 1, 1988
A comparison between the in vivo and in vitro activity of five potent and competitive NMDA antagonistsD Lodge, S N Davies, M G Jones, et al.
Bioorganic & Medicinal Chemistry Letters|May 30, 2001
Arylsulphonyl hydroxamic acids: potent and selective matrix metalloproteinase inhibitorsA D Baxter, R Bhogal, J Bird, et al.
Pageof 3